|
01/02/2016 |
Determination of the local inflammatory response in patients with COPD by wood smoke and COPD per cigarette |
FNC |
Registered |
|
01/02/2016 |
CIGB-370 in patients with malignant tumors |
CIGB |
Registered |
|
01/02/2017 |
NeuroEPO in patients with Mild-Moderate Alzheimer's disease |
CIM |
Registered |
|
01/02/2017 |
NeuroEPO in patients with Parkinson disease stage II-III |
CIM |
Registered |
|
01/03/2021 |
AVATAR-2020 |
CIGB |
Registered |
|
01/08/2018 |
Oncoxin-Viusid / Pancreatic adenocarcinoma / Adults / Phase II |
CATALYSIS |
Registered |
|
01/09/2016 |
1B8 vs MabThera® in patients with Diffuse large B-cell lymphoma |
CIM |
Registered |
|
01/10/2020 |
Safety and efficacy of VAXIRA® in advanced NSCLC patients not progressing after first line chemotherapy. Phase III. |
CIM |
Registered |
|
01/10/2020 |
OLIVO Study |
CIGB |
Registered |
|
01/11/2018 |
Effectiveness of a case management model for the comprehensive provision of health services to pluripathological patients |
FUCS |
Registered |
|
02/08/2018 |
NeuroEPO in stroke |
CIM |
Registered |
|
02/09/2013 |
Policosanol-Atorvastatina for Ictus |
CPN |
Registered |
|
02/09/2013 |
D002/Lyprinol for osteoarthritis |
CPN |
Registered |
|
02/11/2014 |
NeuroEPO – Type 2 Spinocerebellar Ataxia Phase I-II |
CIMAB |
Registered |
|
02/12/2016 |
Abexol and Glucosamine/Chondroitin Sulphate in osteoarthritis: study of the 6 months. |
CPN |
Registered |
|
03/02/2017 |
Phase I/II trial with the mutein no alfa of IL-2 |
CIM |
Registered |
|
03/03/2021 |
SOBERANA 02-FaseIII |
FINLAY |
Registered |
|
03/05/2020 |
Pharmacodynamics of the Nasalferon in healthy volunteers. |
CIGB |
Registered |
|
03/07/2020 |
Stem cells in patients with lung lesions (COVID-19) |
IHI |
Registered |
|
03/07/2020 |
PLASMA TREATMENT TO ASYMPTOMATIC PATIENT WITH COVID-19 INFECTION |
IHI |
Registered |
